Avidity rose 1.2% to close at $49.15 in New York trading Friday, giving the company a market value of about $6.8 billion
Novartis lost its Vymada patent in India, enabling generic drugmakers to launch versions that could slash prices by up to 70 per cent and improve access for cardiac patients
Here is the complete list of stocks that will trade ex-dividend on July 23, following their announcements of dividend rewards for shareholders